Polymer–drug conjugate therapeutics: advances, insights and prospects

Polymer–drug conjugate therapeutics: advances, insights and prospects

Polymer–drug conjugate therapeutics: advances, insights and prospects, Published online: 12 December 2018; doi:10.1038/s41573-018-0005-0

The conjugation of therapeutic agents to polymer carriers, such as polyethylene glycol (PEG), can control drug delivery, enhance solubilization, increase efficacy and improve pharmacokinetics. Here, Grinstaff, Colson and Ekladious discuss recent advances in the preclinical and clinical development of different classes of polymer–drug conjugates and highlight current challenges and future directions.

Articles You May Like

New technique for in-cell distance determination
World’s oldest semen still viable
Novel electrocardiogram uses signals from ear and hand to check heart rhythm
Microbes can grow on nitric oxide
Aspiring Doctors Seek Advanced Training In Addiction Medicine

Leave a Reply

Your email address will not be published. Required fields are marked *